Hikma signs exclusive licensing and distribution agreement with Orion for Easyhaler inhaler

Hikma Pharmaceuticals signed an exclusive licensing and distribution agreement with Orion Corporation to register, distribute, market and sell Orion's Easyhaler inhaler (budesonide/formoterol) for asthma and COPD in all of Hikma's MENA markets.

“We are pleased to be adding this important product to our respiratory pipeline and we hope this collaboration with Orion will be the beginning of a long partnership for its Easyhaler device products in the MENA region.”pharmaceuticaldaily.com

• 1 source
• pharmaceuticaldaily.comHikma won exclusive licensing and distribution agreement for pulmonary disease drug – pharmaceutical dailyDino MustafićFeb 13, 2017

Summarized from public sources; check the original articles before acting on it.